XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Schedule of Fair value Assets and Liabilities Measured on Recurring Basis

The carrying amounts and estimated fair values of the Company’s financial assets and liabilities that were measured at fair value on a recurring basis as of September 30, 2023 and December 31, 2022 were as follows:

 

   September 30, 2023   December 31, 2022 
  

Carrying

Amount

  

Fair

Value

  

Carrying

Amount

  

Fair

Value

 
Cash and cash equivalents  $7,241,811   $7,241,811   $79,845   $79,845 
Senior convertible debentures   4,863,000    4,863,000         
Warrant liabilities   50,738,180    50,738,180         
Schedule of Assets And Liabilities Measured at Fair Value

Assets and liabilities measured at fair value on a recurring basis as of September 30, 2023 are summarized below. There were no assets and liabilities measured at fair value on a recurring basis as of December 31, 2022.

 

                     
   September 30, 2023 
  

Quoted Prices in Active Markets

(Level 1)

  

Significant Other Observable Inputs

(Level 2)

  

Significant Unobservable Inputs Not Corroborated by Market Data

(Level 3)

   Assets (Liabilities) at Fair Value 
Senior convertible debentures  $   $   $4,863,000   $4,863,000 
Warrant liabilities           50,738,180    50,738,180 
Schedule of Senior Convertible Debentures

The significant unobservable inputs used in the Level 3 fair value measurement of the senior convertible debentures as of May 3, 2023 (date of the Merger) and September 30, 2023 and their values are as follows:

   May 3, 2023   September 30, 2023 
Volatility   75%   75%
Yield   20.00%   19.60%
Schedule of Fair Value For Level 3 Liabilities

The table below provides a summary of changes in the fair value of the Company’s Level 3 senior convertible debentures for the three and nine months ended September 30, 2023. There were no Level 3 liabilities in the period from June 7, 2022 (date of inception) through September 30, 2022.

 

  

Three Months

Ended

September 30, 2023

  

Nine Months

Ended

September 30, 2023

 
Balance at beginning of period  $2,722,000   $ 
Senior convertible debentures assumed in the Merger       1,981,000 
Losses reported in earnings   2,141,000    2,882,000 
Balance at September 30, 2023  $4,863,000   $4,863,000 
Schedule of Valuation of Warrant Liabilities

The following table summarizes the Company’s assumptions used in the valuation of warrant liabilities for the three and nine months ended September 30, 2023:

 

    At Initial Warrant Liability Classification   September 30, 2023 
          
Stock price   $6.7114.57   $11.86 
Option exercise price   $6.00   $6.00 
Expected term (years)    4.655.00    4.594.88 
Volatility    75.0%   75.0%
Discount rate    4.27% - 4.39%   4.51% - 4.54%
Schedule of Changes in Fair Value in Warrant Liabilities

The following table sets forth a summary of the changes in the fair value of the Level 3 warrant liabilities for the three and nine months ended September 30, 2023. There were no Level 3 liabilities in the period from June 7, 2022 (date of inception) through September 30, 2022.

 

 Schedule of Changes in Fair Value in Warrant Liabilities

   Three Months
Ended
September 30, 2023
   Nine Months
Ended
September 30, 2023
 
Balance at beginning of period  $   $ 
Reclassification to warrant liabilities   25,883,095    25,883,095 
Change in estimate fair value   24,855,085    24,855,085 
Balance at September 30, 2023  $50,738,180   $50,738,180 

Schedule of Anti-dilutive Securities Excluded from Earnings Per Share

  

Potentially Dilutive Security  Quantity   Stated Value Per Share   Total Value or Stated Value  

Assumed

Conversion Price

  

Resulting Common

Shares

 
Merger Options and restricted stock units(1)   8,641,176   $   $   $    641,176 
Common stock warrants   447,855,367                15,674,938 
AR Debentures           2,000,000    5.00    400,000 
Series D preferred stock   21,799    1,000    21,799,250    5.00    4,359,850 
Series E preferred stock   20,000    1,000    20,000,000    5.00    4,000,000 
                          
Total                       25,075,964 

 

(1) Not exercisable or vested as of September 30, 2023 (see Notes 12 and 13).